CClinicalTrials.gg
CompletedNCT02758444ZEED2Updated Jul 5, 2019

Effects of EED on Zn Absorption and Retention in Children From a MNP

An interventional study of Micronutrient Powder (MNP) + 15 mg Zn and MNP + 10 mg Zn in Environmental Enteric Dysfunction and Zinc Deficiency, sponsored by University of Colorado, Denver. Completed at 2 sites in 2 countries. Open to participants aged 18 Months to 24 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-05.

Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Nov 2015, registered Apr 2016).
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Months to 24 Months
Sex
All
01

Study summary

The overall objective is to determine the impact of EED on total daily zinc absorption of young Bangladeshi children (18-24 months of age) in an austere setting with high rates of diarrhea, stunting, and micro-nutrient deficiencies..

Read the detailed description

Participating children are screened for EED using the lactulose:mannitol ratio test and assigned to one of two groups: +EED or -EED. After assignment to one of the two groups, proposed subjects will be randomized to one of four supplement groups: Micronutrient powder (MNP) with 15 mg Zn, MNP with 10 mg Zn, MNP with 5 mg Zn, and MNP with 0 mg Zn. Children will receive the supplement once with a meal on Day 8 of the study. Absorption of zinc from the supplement and from other non-supplemented meals will be determined using zinc stable isotope technology.

02

Conditions studied

  • Environmental Enteric Dysfunction
  • Zinc Deficiency

Keywords

  • environmental enteric dysfunction
  • environmental enteropathy
  • zinc absorption
  • Bangladesh
  • toddlers
  • zinc isotope
03

In context

Lead sponsor

University of Colorado, Denver is the lead sponsor of 1,499 studies on the registry; 315 are open to participants now.

Of its 139 completed or terminated interventional studies of FDA-regulated products, 89 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Months to 24 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Absence of apparent health problems that would impair ability to consume regular diet, to tolerate zinc supplements, or to comply with demands of metabolic studies
  • Length for age Z (LAZ) score between -1.5 to -3.0
  • Hg ≥ 8

Exclusion criteria

Exclusion Criteria:

  • Outside age range
  • Hb \< 8
  • Chronic illness
  • Zinc supplement within past 2 weeks (including for treatment of diarrhea or MNP containing zinc)
  • Severe stunting and/or severe acute malnutrition (SAM): LAZ \<-3; WHZ \<-3 or MUAC \< 115 or edema
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    Micronutrient Powder (MNP) + 15 mg Zn

    1 sachet of Micronutrient Powder (MNP) + 15 mg Zn will be added to a single meal on study day 8

    Dietary Supplement: Micronutrient Powder (MNP) + 15 mg Zn

  • Active comparator
    MNP + 10 mg Zn

    1 sachet of MNP + 10 mg Zn will be added to a single meal on study day 8

    Dietary Supplement: MNP + 10 mg Zn

  • Active comparator
    MNP + 5 mg Zn

    1 sachet of MNP + 5 mg Zn will be added to a single meal on study day 8

    Dietary Supplement: MNP + 5 mg Zn

  • Placebo comparator
    MNP without Zn

    1 sachet of MNP without Zn will be added to a single meal on study day 8

    Dietary Supplement: MNP without Zn

Interventions

  • Dietary supplementMicronutrient Powder (MNP) + 15 mg Zn

    Children will have the supplement powder added to one meal on study day 1. Absorption of zinc from this meal will be measured using zinc stable isotope techniques.

  • Dietary supplementMNP + 10 mg Zn

    Same as above except MNP will contain 10 mg Zn

  • Dietary supplementMNP + 5 mg Zn

    Same as above except MNP will contain 5 mg Zn

  • Dietary supplementMNP without Zn

    Same as above except MNP will not contain Zn

06

What researchers measure

Primary outcomes

  1. Total daily absorbed zinc (TAZ)

    Measured during the meal to determine the effects of EED on zinc absorption.

    Time frame: 1 day

Secondary outcomes

  1. Exchangeable zinc pool (EZP)

    Size of exchangeable Zn pool (EZP) measured with zinc isotope methods prior to the meal.

    Time frame: 1 day

  2. Plasma zinc

    Measured prior to the meal.

    Time frame: 1 day

  3. Alkaline phosphatase

    Measured prior to the meal.

    Time frame: 1 day

  4. Serum retinol

    Measured prior to the meal.

    Time frame: 1 day

  5. Methyl malonic acid

    Measured prior to the meal.

    Time frame: 1 day

  6. Vitamin B12

    Measured prior to the meal.

    Time frame: 1 day

  7. Serum ferritin

    Measured prior to the meal.

    Time frame: 1 day

  8. Soluble transferrin receptors

    Measured prior to the meal.

    Time frame: 1 day

  9. CRP

    Measured prior to the meal.

    Time frame: 1 day

  10. AGP

    Measured prior to the meal.

    Time frame: 1 day

  11. TNF alpha

    Measured prior to the meal.

    Time frame: 1 day

  12. Serum endocab

    Measured prior to the meal.

    Time frame: 1 day

  13. Neopterin

    Measured prior to the meal.

    Time frame: 1 day

  14. Myeloperoxidase

    Measured prior to the meal.

    Time frame: 1 day

  15. Calprotectin

    Measured prior to the meal.

    Time frame: 1 day

  16. alpha 1 antitrypsin

    Measured prior to the meal.

    Time frame: 1 day

07

Study locations

2 sites
  • University of Colorado Denver
    Aurora, Colorado 80045, United States
  • icddr,b (International Centre for Diarrheal Disease Research, Bangladesh
    Dhaka, Bangladesh
08

References and documents

Publications

  • Long JM, Mondal P, Westcott JE, Miller LV, Islam MM, Ahmed M, Mahfuz M, Ahmed T, Krebs NF. Zinc Absorption from Micronutrient Powders Is Low in Bangladeshi Toddlers at Risk of Environmental Enteric Dysfunction and May Increase Dietary Zinc Requirements. J Nutr. 2019 Jan 1;149(1):98-105. doi: 10.1093/jn/nxy245. PubMed 30624753 ↗

Individual participant data

Plan to share: Yes

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 5, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02758444
Lead sponsor
University of Colorado, Denver
Collaborators
International Centre for Diarrhoeal Disease Research, Bangladesh
Responsible party
Sponsor
First posted
May 2, 2016
Start date
Nov 2015
Primary completion
Mar 2018
Completion
Feb 2019
Last update
Jul 5, 2019

Study contacts

Nancy F Krebs, MD, MS
principal investigator · University of Colorado, Denver

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion